{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T20:22:33Z","timestamp":1782591753467,"version":"3.54.5"},"reference-count":12,"publisher":"Japan Atherosclerosis Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2023,3,1]]},"DOI":"10.5551\/jat.63473","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T22:10:20Z","timestamp":1653084620000},"page":"222-236","source":"Crossref","is-referenced-by-count":25,"title":["Efficacy and Safety of Prasugrel vs Clopidogrel in Thrombotic Stroke Patients With Risk Factors for Ischemic Stroke Recurrence: A Double-blind, Phase III Study (PRASTRO-III)"],"prefix":"10.5551","volume":"30","author":[{"given":"Takanari","family":"Kitazono","sequence":"first","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kamouchi","sequence":"additional","affiliation":[{"name":"Department of Health Care Administration and Management, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Matsumaru","sequence":"additional","affiliation":[{"name":"Division of Stroke Prevention and Treatment, Department of Neurosurgery, Faculty of Medicine, University of Tsukuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Toho University Ohashi Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Umemura","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Hamamatsu University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Co., Ltd.,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Koyama","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Co., Ltd.,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Tsutsumi","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Co., Ltd.,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","unstructured":"1) Japan Stroke Society Committee on Guidelines for the Management of Stroke. Japanese guidelines for the management of stroke, updated version 2019. Tokyo: Kyowa Kikaku. pp. 42-54"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Wiviott SD, Trenk D, Frelinger AL, O\u2019Donoghue M, Neumann FJ, Michelson AD, O\u2019Donoghue M, Neumann FJ, Michelson AD, Angiolillo DJ, Hod H, Montalescot G, Miller DL, Jakubowski JA, Cairns R, Murphy SA, McCabe CH, Antman EM, Braunwald E: PRINCIPLE-TIMI 44 Investigators. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation, 2007; 116: 2923-2932","DOI":"10.1161\/CIRCULATIONAHA.107.740324"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM: TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med, 2007; 357: 2001-2015","DOI":"10.1056\/NEJMoa0706482"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, Takayama M, Kitagawa K, Nishikawa M, Miyazaki S, Ikeda Y, Nakamura M, Saito S, PRASFIT-Elective Investigators. Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention. Circ J, 2014; 78: 2926-2934","DOI":"10.1253\/circj.CJ-14-0266"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Saito S, Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, Takayama M, Kitagawa L, Nishikawa M, Miyazaki S, Nakamura M. Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: The PRASFIT-ACS study. Circ J, 2014; 78: 1684-1692","DOI":"10.1253\/circj.CJ-13-1482"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ogawa A, Toyoda K, Kitagawa K, Kitazono T, Nagao T, Yamagami H, Uchiyama S, Tanahashi N, Matsumoto M, Minematsu K, Nagata I, Nishikawa M, Nanto S, Abe K, Ikeda Y; PRASTRO-I Study Group. Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: A phase 3, randomised, non-inferiority trial (PRASTRO-I). Lancet Neurol, 2019; 18: 238-247","DOI":"10.1016\/S1474-4422(18)30449-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kitagawa K, Toyoda K, Kitazono T, Nishikawa M, Nanto S, Ikeda Y, Abe K, Ogawa A. Safety and efficacy of prasugrel in elderly\/low body weight Japanese patients with ischemic stroke: Randomized PRASTRO-II. Cerebrovasc Dis, 2020; 49: 152-159","DOI":"10.1159\/000506825"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Liu L, Wong KS, Leng X, Pu Y, Wang Y, Jing J, Zou X, Pan Y, Wang A, Xia Meng X, Wang C, Zhao X, Soo Y, Johnston SC, Wang Y, CHANCE Investigators. Dual antiplatelet therapy in stroke and ICAS: Subgroup analysis of CHANCE. Neurology, 2015; 85: 1154-1162","DOI":"10.1212\/WNL.0000000000001972"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Hill MD, Jonasson J, Kasner SE, Ladenvall P, Minematsu K, Molina CA, Wang Y, Wong KSL, Johnston SC, SOCRATES Steering Committee and Investigators. Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: A subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. Lancet Neurol, 2017; 16: 301-310","DOI":"10.1016\/S1474-4422(17)30038-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kitazono T, Toyoda K, Kitagawa K, Nagao T, Yamagami H, Uchiyama S, Tanahashi N, Matsumoto M, Minematsu K, Nagata I, Nishikawa M, Nanto S, Ikeda Y, Shirai T, Abe K, Ogawa A. Efficacy and safety of prasugrel by stroke subtype: A sub-analysis of the PRASTRO-I randomized controlled trial. J Atheroscler Thromb, 2021; 28: 169-180","DOI":"10.5551\/jat.56093"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 1993; 24: 35-41","DOI":"10.1161\/01.STR.24.1.35"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Johnston SC, Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CA, Wang Y; for the THALES Investigators. Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA. N Engl J Med, 2020; 383: 207-217","DOI":"10.1056\/NEJMoa1916870"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/3\/30_63473\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T04:34:03Z","timestamp":1677904443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/3\/30_63473\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.63473","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"article-number":"63473"}}